Case Commentary: Novel Therapy for Multidrug-Resistant Acinetobacter baumannii Infection.
Brianna M EalesVincent H TamPublished in: Antimicrobial agents and chemotherapy (2021)
Acinetobacter baumannii is a pathogenic bacterium commonly associated with multidrug resistance. In this issue of Antimicrobial Agents and Chemotherapy, Rao et al. present a challenging case of ventilator-associated pneumonia in which bacteriophage therapy was used as a last resort treatment in combination with systemic antibiotics (S. Rao, M. Betancourt-Garcia, Y. O. Kare-Opaneye, B. E. Swiercezewski, et al., Antimicrob Agents Chemother, 2021, https://doi.org/10.1128/AAC.00824-21). The data are promising, and several key areas are highlighted for future research.
Keyphrases
- acinetobacter baumannii
- multidrug resistant
- drug resistant
- pseudomonas aeruginosa
- gram negative
- klebsiella pneumoniae
- electronic health record
- staphylococcus aureus
- cystic fibrosis
- squamous cell carcinoma
- locally advanced
- acute respiratory distress syndrome
- replacement therapy
- deep learning
- rectal cancer
- bone marrow
- data analysis